NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1002291463|ref|XP_015650076|]
View 

protein ENHANCED DISEASE RESISTANCE 2-like [Oryza sativa Japonica Group]

Protein Classification

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PLN00188 super family cl33420
enhanced disease resistance protein (EDR2); Provisional
52-761 1.34e-113

enhanced disease resistance protein (EDR2); Provisional


The actual alignment was detected with superfamily member PLN00188:

Pssm-ID: 215094 [Multi-domain]  Cd Length: 719  Bit Score: 360.28  E-value: 1.34e-113
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463  52 WVYHLGVNSIGHEYRHLRFLVIRGKTVAMYKRDPSKNpgIQPIRKGVVSHTLMVEELGRRiTSHGE-LYVLRFYNRLDQT 130
Cdd:PLN00188    9 WMVRYGRRKIGRSYIHMRYFVLESRLLAYYKKKPQDN--QVPIKTLLIDGNCRVEDRGLK-THHGHmVYVLSVYNKKEKY 85
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 131 KKGEIACGDPGEARKWVEAFE------QAKQQA--------DYDL-MTRGVSWNRSQNENELNL-----DGHRPRVRRya 190
Cdd:PLN00188   86 HRITMAAFNIQEALIWKEKIEsvidqhQDSQVPngnkyasfEYKSgMDNGRTASSSDHESQFSAqedeeDTHRDLLRR-- 163
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 191 qglgklVRIGKGPEKLLRQSSNLQSHEIINTNfggDSGDAFEAHEWRYVRTFNGIRIFEDIANTK---GGKGVLLKSVGV 267
Cdd:PLN00188  164 ------TTIGNGPPDSVLDWTKEFDSELSNQN---SNNQAFSRKHWRLLQCQNGLRIFEELLEVDylpRSCSRAMKAVGV 234
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 268 VGANPDTVFAVVLSSDKhKRYEWDMLTADLELVETIDGYYDVVYGTYEpryLSWWKT---KKDFVFSRQWFRGQDGAYTI 344
Cdd:PLN00188  235 VEATCEEIFELVMSMDG-TRFEWDCSFQYGSLVEEVDGHTAILYHRLQ---LDWFPMfvwPRDLCYVRYWRRNDDGSYVV 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 345 LQIPACHKNKPPRHGYERTKINSSTWELRRLNPPgSSTPKCLVTHMLEMSpsfWDRWKRRHNENFDRSIAFALLSQVAGL 424
Cdd:PLN00188  311 LFRSREHENCGPQPGFVRAHLESGGFNISPLKPR-NGRPRTQVQHLMQID---LKGWGVGYIPSFQQHCLLQMLNSVAGL 386
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 425 REYFA--------------ANPALTSDLPSTVVKPKQSDSLIIQSEL---------EDSELNDEFydalargesfededs 481
Cdd:PLN00188  387 REWFSqtdergappripvmVNMASASVSSKKNQKPQESSPSLDQTNAasrnsvmmdEDSDDDEEF--------------- 451
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 482 dddddMIPKAGKVKFkniswaiaglamkPTKASVEKSELvTNSTPVTIDSNHFHGTLRRAKSENDPNSWSEPGGEKFMIR 561
Cdd:PLN00188  452 -----QIPESEQEPE-------------TTKNETKDTAM-EEEPQDKIDLSCFSGNLRRDDRDKARDCWRISDGNNFKVR 512
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 562 GKTYLTDYTKVVGGDPLLKLIAVDWFKADERFDSVALHPKSLVQSeAAKKIPFILVINLQVPAKPNYNLVMYYAAERPVn 641
Cdd:PLN00188  513 SKNFCYDKSKIPAGKHLMDLVAVDWFKDTKRMDHVARRKGCAAQV-AAEKGLFSFVVNLQVPGSTHYSMVFYFVTKELV- 590
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 642 KDSLLGRFIDGTDAFRDARFKLIPSIVEGYWMVKRAVGTKACLLGKAVTCNYLRQDNFLEIDVDIGSSSVARSIIGLVLG 721
Cdd:PLN00188  591 PGSLLQRFVDGDDEFRNSRLKLIPSVPKGSWIVRQSVGSTPCLLGKAVDCNYIRGPKYLEIDVDIGSSTVANGVLGLVIG 670
                         730       740       750       760
                  ....*....|....*....|....*....|....*....|
gi 1002291463 722 YVTGLVVDLAILIEAKEEKELPEYILGTVRLNRANPDSAV 761
Cdd:PLN00188  671 VITTLVVDMAFLVQANTYEELPERLIGAVRVSHVELSSAI 710
 
Name Accession Description Interval E-value
PLN00188 PLN00188
enhanced disease resistance protein (EDR2); Provisional
52-761 1.34e-113

enhanced disease resistance protein (EDR2); Provisional


Pssm-ID: 215094 [Multi-domain]  Cd Length: 719  Bit Score: 360.28  E-value: 1.34e-113
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463  52 WVYHLGVNSIGHEYRHLRFLVIRGKTVAMYKRDPSKNpgIQPIRKGVVSHTLMVEELGRRiTSHGE-LYVLRFYNRLDQT 130
Cdd:PLN00188    9 WMVRYGRRKIGRSYIHMRYFVLESRLLAYYKKKPQDN--QVPIKTLLIDGNCRVEDRGLK-THHGHmVYVLSVYNKKEKY 85
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 131 KKGEIACGDPGEARKWVEAFE------QAKQQA--------DYDL-MTRGVSWNRSQNENELNL-----DGHRPRVRRya 190
Cdd:PLN00188   86 HRITMAAFNIQEALIWKEKIEsvidqhQDSQVPngnkyasfEYKSgMDNGRTASSSDHESQFSAqedeeDTHRDLLRR-- 163
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 191 qglgklVRIGKGPEKLLRQSSNLQSHEIINTNfggDSGDAFEAHEWRYVRTFNGIRIFEDIANTK---GGKGVLLKSVGV 267
Cdd:PLN00188  164 ------TTIGNGPPDSVLDWTKEFDSELSNQN---SNNQAFSRKHWRLLQCQNGLRIFEELLEVDylpRSCSRAMKAVGV 234
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 268 VGANPDTVFAVVLSSDKhKRYEWDMLTADLELVETIDGYYDVVYGTYEpryLSWWKT---KKDFVFSRQWFRGQDGAYTI 344
Cdd:PLN00188  235 VEATCEEIFELVMSMDG-TRFEWDCSFQYGSLVEEVDGHTAILYHRLQ---LDWFPMfvwPRDLCYVRYWRRNDDGSYVV 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 345 LQIPACHKNKPPRHGYERTKINSSTWELRRLNPPgSSTPKCLVTHMLEMSpsfWDRWKRRHNENFDRSIAFALLSQVAGL 424
Cdd:PLN00188  311 LFRSREHENCGPQPGFVRAHLESGGFNISPLKPR-NGRPRTQVQHLMQID---LKGWGVGYIPSFQQHCLLQMLNSVAGL 386
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 425 REYFA--------------ANPALTSDLPSTVVKPKQSDSLIIQSEL---------EDSELNDEFydalargesfededs 481
Cdd:PLN00188  387 REWFSqtdergappripvmVNMASASVSSKKNQKPQESSPSLDQTNAasrnsvmmdEDSDDDEEF--------------- 451
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 482 dddddMIPKAGKVKFkniswaiaglamkPTKASVEKSELvTNSTPVTIDSNHFHGTLRRAKSENDPNSWSEPGGEKFMIR 561
Cdd:PLN00188  452 -----QIPESEQEPE-------------TTKNETKDTAM-EEEPQDKIDLSCFSGNLRRDDRDKARDCWRISDGNNFKVR 512
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 562 GKTYLTDYTKVVGGDPLLKLIAVDWFKADERFDSVALHPKSLVQSeAAKKIPFILVINLQVPAKPNYNLVMYYAAERPVn 641
Cdd:PLN00188  513 SKNFCYDKSKIPAGKHLMDLVAVDWFKDTKRMDHVARRKGCAAQV-AAEKGLFSFVVNLQVPGSTHYSMVFYFVTKELV- 590
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 642 KDSLLGRFIDGTDAFRDARFKLIPSIVEGYWMVKRAVGTKACLLGKAVTCNYLRQDNFLEIDVDIGSSSVARSIIGLVLG 721
Cdd:PLN00188  591 PGSLLQRFVDGDDEFRNSRLKLIPSVPKGSWIVRQSVGSTPCLLGKAVDCNYIRGPKYLEIDVDIGSSTVANGVLGLVIG 670
                         730       740       750       760
                  ....*....|....*....|....*....|....*....|
gi 1002291463 722 YVTGLVVDLAILIEAKEEKELPEYILGTVRLNRANPDSAV 761
Cdd:PLN00188  671 VITTLVVDMAFLVQANTYEELPERLIGAVRVSHVELSSAI 710
EDR2_C pfam07059
Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus ...
550-754 3.53e-99

Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus (approximately 250 residues) of protein ENHANCED DISEASE RESISTANCE 2 (EDR2) from plants. EDR2 is a negative regulator of the salicylic acid (SA)-mediated resistance to pathogens, including the biotrophic powdery mildew pathogens Golovinomyces cichoracearum and Blumeria graminis, and the downy mildew pathogen Hyaloperonospora parasitica, probably by limiting the initiation of cell death and the establishment of the hypersensitive response (HR).


Pssm-ID: 462076  Cd Length: 211  Bit Score: 305.29  E-value: 3.53e-99
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 550 WSEPGGEKFMIRGKTYLTDYTKVVGGDPLLKLIAVDWFKADERFDSVALHPKSLV-----QSEAAKKIPFILVINLQVPA 624
Cdd:pfam07059   1 WSEPDGSTFKVRGPNYLKDKKKVPAGPPLYELVGVDLFKSPKKIDHIASRPELPValkpsEKGASGKVPFVFVVNLQVPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 625 kPNYNLVMYYAAERPVNKD--SLLGRFIDGTDAFRDARFKLIPSIVEGYWMVKRAVGTKACLLGKAVTCNYLRQDNFLEI 702
Cdd:pfam07059  81 -PGYSLVLYFATEEPLPDDegSLLDRFVDGDDAFRNERFKLIPRIVNGPWIVKQAVGGKPVLIGKALTCKYHRGHNYFEI 159
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 1002291463 703 DVDIGSSSVARSIIGLVLGYVTGLVVDLAILIEAKEEKELPEYILGTVRLNR 754
Cdd:pfam07059 160 DVDIHSSSYARKGLSLVLGYLKSLVVDLGFTIEGQTEEELPERLLGAVRLNK 211
START cd00177
Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family ...
232-398 4.95e-35

Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family includes the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domains of mammalian STARD1-STARD15, and related domains, such as the START domain of the Arabidopsis homeobox protein GLABRA 2. The mammalian STARDs are grouped into 8 subfamilies. This family belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) domain superfamily of proteins that bind hydrophobic ligands. SRPBCC domains have a deep hydrophobic ligand-binding pocket. For some members of this family, specific lipids that bind in this pocket are known; these include cholesterol (STARD1/STARD3/ STARD4/STARD5), 25-hydroxycholesterol (STARD5), phosphatidylcholine (STARD2/ STARD7/STARD10), phosphatidylethanolamine (STARD10) and ceramides (STARD11). The START domain is found either alone or in association with other domains. Mammalian STARDs participate in the control of various cellular processes including lipid trafficking between intracellular compartments, lipid metabolism, and modulation of signaling events. Mutation or altered expression of STARDs is linked to diseases such as cancer, genetic disorders, and autoimmune disease. The Arabidopsis homeobox protein GLABRA 2 suppresses root hair formation in hairless epidermal root cells.


Pssm-ID: 176851 [Multi-domain]  Cd Length: 193  Bit Score: 131.69  E-value: 4.95e-35
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 232 EAHEWRYVRTFNGIRIFEDIanTKGGKGVLLKSVGVVGANPDTVFAVVLssDKHKRYEWDMLTADLELVETIDGYYDVVY 311
Cdd:cd00177    13 EPEGWKLVKEKDGVKIYTKP--YEDSGLKLLKAEGVIPASPEQVFELLM--DIDLRKKWDKNFEEFEVIEEIDEHTDIIY 88
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 312 GTYEPRylsWWKTKKDFVFSRQWFRGQDGAYTILQIPACHKNKPPRHGYERTKINSSTWELRRLNPpgsstPKCLVTHML 391
Cdd:cd00177    89 YKTKPP---WPVSPRDFVYLRRRRKLDDGTYVIVSKSVDHDSHPKEKGYVRAEIKLSGWIIEPLDP-----GKTKVTYVL 160

                  ....*..
gi 1002291463 392 EMSPSFW 398
Cdd:cd00177   161 QVDPKGS 167
START smart00234
in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and ...
262-391 4.83e-07

in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and phosphatidylcholine transfer protein


Pssm-ID: 214575  Cd Length: 205  Bit Score: 50.89  E-value: 4.83e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463  262 LKSVGVVGANPDTVFAVVLSsDKHKRYEWDMLTADLELVETIDG----YYDV---VYGTYEPRylswwktkkDFVFSRQW 334
Cdd:smart00234  46 FRLVGVVPMVCADLVEELMD-DLEYRPEWDKNVAKAETLEVIDNgtviYHYVskfAAGPVSPR---------DFVFVRYW 115
                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 1002291463  335 FRGQDGAYTILQIPACHKNKPPRHGYERTKINSStweLRRLNPPGSstPKCLVTHML 391
Cdd:smart00234 116 REDEDGSYAVVDVSVTHPTSPPESGYVRAENLPS---GLLIEPLGN--GPSKVTWVS 167
 
Name Accession Description Interval E-value
PLN00188 PLN00188
enhanced disease resistance protein (EDR2); Provisional
52-761 1.34e-113

enhanced disease resistance protein (EDR2); Provisional


Pssm-ID: 215094 [Multi-domain]  Cd Length: 719  Bit Score: 360.28  E-value: 1.34e-113
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463  52 WVYHLGVNSIGHEYRHLRFLVIRGKTVAMYKRDPSKNpgIQPIRKGVVSHTLMVEELGRRiTSHGE-LYVLRFYNRLDQT 130
Cdd:PLN00188    9 WMVRYGRRKIGRSYIHMRYFVLESRLLAYYKKKPQDN--QVPIKTLLIDGNCRVEDRGLK-THHGHmVYVLSVYNKKEKY 85
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 131 KKGEIACGDPGEARKWVEAFE------QAKQQA--------DYDL-MTRGVSWNRSQNENELNL-----DGHRPRVRRya 190
Cdd:PLN00188   86 HRITMAAFNIQEALIWKEKIEsvidqhQDSQVPngnkyasfEYKSgMDNGRTASSSDHESQFSAqedeeDTHRDLLRR-- 163
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 191 qglgklVRIGKGPEKLLRQSSNLQSHEIINTNfggDSGDAFEAHEWRYVRTFNGIRIFEDIANTK---GGKGVLLKSVGV 267
Cdd:PLN00188  164 ------TTIGNGPPDSVLDWTKEFDSELSNQN---SNNQAFSRKHWRLLQCQNGLRIFEELLEVDylpRSCSRAMKAVGV 234
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 268 VGANPDTVFAVVLSSDKhKRYEWDMLTADLELVETIDGYYDVVYGTYEpryLSWWKT---KKDFVFSRQWFRGQDGAYTI 344
Cdd:PLN00188  235 VEATCEEIFELVMSMDG-TRFEWDCSFQYGSLVEEVDGHTAILYHRLQ---LDWFPMfvwPRDLCYVRYWRRNDDGSYVV 310
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 345 LQIPACHKNKPPRHGYERTKINSSTWELRRLNPPgSSTPKCLVTHMLEMSpsfWDRWKRRHNENFDRSIAFALLSQVAGL 424
Cdd:PLN00188  311 LFRSREHENCGPQPGFVRAHLESGGFNISPLKPR-NGRPRTQVQHLMQID---LKGWGVGYIPSFQQHCLLQMLNSVAGL 386
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 425 REYFA--------------ANPALTSDLPSTVVKPKQSDSLIIQSEL---------EDSELNDEFydalargesfededs 481
Cdd:PLN00188  387 REWFSqtdergappripvmVNMASASVSSKKNQKPQESSPSLDQTNAasrnsvmmdEDSDDDEEF--------------- 451
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 482 dddddMIPKAGKVKFkniswaiaglamkPTKASVEKSELvTNSTPVTIDSNHFHGTLRRAKSENDPNSWSEPGGEKFMIR 561
Cdd:PLN00188  452 -----QIPESEQEPE-------------TTKNETKDTAM-EEEPQDKIDLSCFSGNLRRDDRDKARDCWRISDGNNFKVR 512
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 562 GKTYLTDYTKVVGGDPLLKLIAVDWFKADERFDSVALHPKSLVQSeAAKKIPFILVINLQVPAKPNYNLVMYYAAERPVn 641
Cdd:PLN00188  513 SKNFCYDKSKIPAGKHLMDLVAVDWFKDTKRMDHVARRKGCAAQV-AAEKGLFSFVVNLQVPGSTHYSMVFYFVTKELV- 590
                         650       660       670       680       690       700       710       720
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 642 KDSLLGRFIDGTDAFRDARFKLIPSIVEGYWMVKRAVGTKACLLGKAVTCNYLRQDNFLEIDVDIGSSSVARSIIGLVLG 721
Cdd:PLN00188  591 PGSLLQRFVDGDDEFRNSRLKLIPSVPKGSWIVRQSVGSTPCLLGKAVDCNYIRGPKYLEIDVDIGSSTVANGVLGLVIG 670
                         730       740       750       760
                  ....*....|....*....|....*....|....*....|
gi 1002291463 722 YVTGLVVDLAILIEAKEEKELPEYILGTVRLNRANPDSAV 761
Cdd:PLN00188  671 VITTLVVDMAFLVQANTYEELPERLIGAVRVSHVELSSAI 710
EDR2_C pfam07059
Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus ...
550-754 3.53e-99

Protein ENHANCED DISEASE RESISTANCE 2, C-terminal; This family represents the C-terminus (approximately 250 residues) of protein ENHANCED DISEASE RESISTANCE 2 (EDR2) from plants. EDR2 is a negative regulator of the salicylic acid (SA)-mediated resistance to pathogens, including the biotrophic powdery mildew pathogens Golovinomyces cichoracearum and Blumeria graminis, and the downy mildew pathogen Hyaloperonospora parasitica, probably by limiting the initiation of cell death and the establishment of the hypersensitive response (HR).


Pssm-ID: 462076  Cd Length: 211  Bit Score: 305.29  E-value: 3.53e-99
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 550 WSEPGGEKFMIRGKTYLTDYTKVVGGDPLLKLIAVDWFKADERFDSVALHPKSLV-----QSEAAKKIPFILVINLQVPA 624
Cdd:pfam07059   1 WSEPDGSTFKVRGPNYLKDKKKVPAGPPLYELVGVDLFKSPKKIDHIASRPELPValkpsEKGASGKVPFVFVVNLQVPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 625 kPNYNLVMYYAAERPVNKD--SLLGRFIDGTDAFRDARFKLIPSIVEGYWMVKRAVGTKACLLGKAVTCNYLRQDNFLEI 702
Cdd:pfam07059  81 -PGYSLVLYFATEEPLPDDegSLLDRFVDGDDAFRNERFKLIPRIVNGPWIVKQAVGGKPVLIGKALTCKYHRGHNYFEI 159
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|..
gi 1002291463 703 DVDIGSSSVARSIIGLVLGYVTGLVVDLAILIEAKEEKELPEYILGTVRLNR 754
Cdd:pfam07059 160 DVDIHSSSYARKGLSLVLGYLKSLVVDLGFTIEGQTEEELPERLLGAVRLNK 211
START cd00177
Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family ...
232-398 4.95e-35

Lipid-binding START domain of mammalian STARD1-STARD15 and related proteins; This family includes the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domains of mammalian STARD1-STARD15, and related domains, such as the START domain of the Arabidopsis homeobox protein GLABRA 2. The mammalian STARDs are grouped into 8 subfamilies. This family belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) domain superfamily of proteins that bind hydrophobic ligands. SRPBCC domains have a deep hydrophobic ligand-binding pocket. For some members of this family, specific lipids that bind in this pocket are known; these include cholesterol (STARD1/STARD3/ STARD4/STARD5), 25-hydroxycholesterol (STARD5), phosphatidylcholine (STARD2/ STARD7/STARD10), phosphatidylethanolamine (STARD10) and ceramides (STARD11). The START domain is found either alone or in association with other domains. Mammalian STARDs participate in the control of various cellular processes including lipid trafficking between intracellular compartments, lipid metabolism, and modulation of signaling events. Mutation or altered expression of STARDs is linked to diseases such as cancer, genetic disorders, and autoimmune disease. The Arabidopsis homeobox protein GLABRA 2 suppresses root hair formation in hairless epidermal root cells.


Pssm-ID: 176851 [Multi-domain]  Cd Length: 193  Bit Score: 131.69  E-value: 4.95e-35
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 232 EAHEWRYVRTFNGIRIFEDIanTKGGKGVLLKSVGVVGANPDTVFAVVLssDKHKRYEWDMLTADLELVETIDGYYDVVY 311
Cdd:cd00177    13 EPEGWKLVKEKDGVKIYTKP--YEDSGLKLLKAEGVIPASPEQVFELLM--DIDLRKKWDKNFEEFEVIEEIDEHTDIIY 88
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 312 GTYEPRylsWWKTKKDFVFSRQWFRGQDGAYTILQIPACHKNKPPRHGYERTKINSSTWELRRLNPpgsstPKCLVTHML 391
Cdd:cd00177    89 YKTKPP---WPVSPRDFVYLRRRRKLDDGTYVIVSKSVDHDSHPKEKGYVRAEIKLSGWIIEPLDP-----GKTKVTYVL 160

                  ....*..
gi 1002291463 392 EMSPSFW 398
Cdd:cd00177   161 QVDPKGS 167
START pfam01852
START domain;
259-408 1.09e-07

START domain;


Pssm-ID: 426476  Cd Length: 205  Bit Score: 52.79  E-value: 1.09e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 259 GVLLKSVGVVGANPDTVFAVVLSsDKHKRYEWDMLTADLELVETIDGYYDVVY--------GTYEPRylswwktkkDFVF 330
Cdd:pfam01852  42 GEASRASGVVPMVAALLVAELLK-DMEYRAQWDKDVRSAETLEVISSGGDLQYyvaalvapSPLSPR---------DFVF 111
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 331 SRQWFRGQDGAYTILQIPACHKNKPPRHGYERTKINSSTWELRRLNPPGS------------STPKCLVTHMLEMS-PSF 397
Cdd:pfam01852 112 LRYWRRLGGGVYVIVDRSVTHPQFPPSSGYVRAERLPSGYLIQPCGNGPSkvtwvshadlkgWLPSWLLRSLYKSGmPEG 191
                         170
                  ....*....|.
gi 1002291463 398 WDRWKRRHNEN 408
Cdd:pfam01852 192 AKTWVATLQRL 202
START smart00234
in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and ...
262-391 4.83e-07

in StAR and phosphatidylcholine transfer protein; putative lipid-binding domain in StAR and phosphatidylcholine transfer protein


Pssm-ID: 214575  Cd Length: 205  Bit Score: 50.89  E-value: 4.83e-07
                           10        20        30        40        50        60        70        80
                   ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463  262 LKSVGVVGANPDTVFAVVLSsDKHKRYEWDMLTADLELVETIDG----YYDV---VYGTYEPRylswwktkkDFVFSRQW 334
Cdd:smart00234  46 FRLVGVVPMVCADLVEELMD-DLEYRPEWDKNVAKAETLEVIDNgtviYHYVskfAAGPVSPR---------DFVFVRYW 115
                           90       100       110       120       130
                   ....*....|....*....|....*....|....*....|....*....|....*..
gi 1002291463  335 FRGQDGAYTILQIPACHKNKPPRHGYERTKINSStweLRRLNPPGSstPKCLVTHML 391
Cdd:smart00234 116 REDEDGSYAVVDVSVTHPTSPPESGYVRAENLPS---GLLIEPLGN--GPSKVTWVS 167
START_STARD1_3_like cd08868
Cholesterol-binding START domain of mammalian STARD1, -3 and related proteins; This subfamily ...
257-430 6.67e-03

Cholesterol-binding START domain of mammalian STARD1, -3 and related proteins; This subfamily includes the steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domains of STARD1 (also known as StAR) and STARD3 (also known as metastatic lymph node 64/MLN64). The START domain family belongs to the SRPBCC (START/RHO_alpha_C/PITP/Bet_v1/CoxG/CalC) domain superfamily of proteins that bind hydrophobic ligands. SRPBCC domains have a deep hydrophobic ligand-binding pocket. This STARD1-like subfamily has a high affinity for cholesterol. STARD1/StAR can reduce macrophage lipid content and inflammatory status. It plays an essential role in steroidogenic tissues: transferring the steroid precursor, cholesterol, from the outer to the inner mitochondrial membrane, across the aqueous space. Mutations in the gene encoding STARD1/StAR can cause lipid congenital adrenal hyperplasia (CAH), an autosomal recessive disorder characterized by a steroid synthesis deficiency and an accumulation of cholesterol in the adrenal glands and the gonads. STARD3 may function in trafficking endosomal cholesterol to a cytosolic acceptor or membrane. In addition to having a cytoplasmic START cholesterol-binding domain, STARD3 also contains an N-terminal MENTAL cholesterol-binding and protein-protein interaction domain. The MENTAL domain contains transmembrane helices and anchors MLN64 to endosome membranes. The gene encoding STARD3 is overexpressed in about 25% of breast cancers.


Pssm-ID: 176877  Cd Length: 208  Bit Score: 38.88  E-value: 6.67e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 257 GKGVLLKsvGVVGANPDTVFAVvLSSDKHKRYEWDMLTADLELVETIDGYYDVVY--------GTYEPRylswwktkkDF 328
Cdd:cd08868    47 GKVFRLT--GVLDCPAEFLYNE-LVLNVESLPSWNPTVLECKIIQVIDDNTDISYqvaaeaggGLVSPR---------DF 114
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1002291463 329 VFSRQWFRGQDGaYTILQIPACHKNKPPRHGYERTKINSSTWELRrlnPPGSSTPKCLVTHMLEMSPSFWDRWKRRhnen 408
Cdd:cd08868   115 VSLRHWGIRENC-YLSSGVSVEHPAMPPTKNYVRGENGPGCWILR---PLPNNPNKCNFTWLLNTDLKGWLPQYLV---- 186
                         170       180
                  ....*....|....*....|..
gi 1002291463 409 fDRSIAFALLSQVAGLREYFAA 430
Cdd:cd08868   187 -DQALASVLLDFMKHLRKRIAT 207
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH